Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0002871 (anemia)
 52,094 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The 12th World AIDS Conference in Geneva reported disturbing metabolic side effects from potent new therapies, particularly those therapies that use protease inhibitors. Cases of lipodystrophy, hypercholesterole anemia, and coronary artery disease have been reported. Conference attendees also discussed a need for a new definition of AIDS-related wasting. One proposed definition was the involuntary loss of 3 percent body weight in 1 month, 5 percent in 6 months, or 10 percent and greater in 12 months. Diarrhea is a major consequence of wasting and antiretroviral therapies, however, it seems more controllable because of a new drug called Provir (SP-303).
 ...
PMID:Metabolic consequences present new challenge. 1136 85